Cathepsin E as a Marker of Colon Cancer

Description:

 The identification of molecular markers and proteomic patterns in the inception and progression of colon cancer is a major goal in the management of this disease. Elevated levels of cathepsin E are detectable in  urine and a diagnostic/screening method for detecting colorectal is disclosed. A method for transcriptionally profiling an patient to monitor the progression of colorectal disease is provided.

 

Patent Information:
Category(s):
Medical Diagnostics
For Information, Contact:
Richard Cox
Director, Technology Commercialization
University of Notre Dame
(574) 631-5158
rcox4@nd.edu
Inventors:
Mary Prorok
Francis Castellino
Rudolph Navari
Keywords:
© 2017. All Rights Reserved. Powered by Inteum